The FDA has approved a new test for the “superbug” methicillin-resistant Staphylococcus aureus (MRSA), according to the manufacturer, Waltham, MA-based Thermo Fisher Scientific (NYSE: [[ticker:TMO]]). The test, called Spectra MRSA, gives results within a day and integrates with routine lab systems to aid healthcare facilities’ efforts to screen their patients, the company said.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
